The 78th World Health Assembly (WHA78), held in Geneva from 19 to 27 May 2025, placed a spotlight on antimicrobial resistance (AMR) as a critical threat to global health and sustainable development. During the Assembly, Member States endorsed the update of the Global Action Plan on AMR, reaffirming their commitment to combat one of the most urgent and complex challenges facing healthcare systems worldwide.
The revised Global Action Plan aims to reduce AMR-related mortality, improve surveillance and access to diagnostics, and promote the responsible use of antimicrobials in human, animal, and environmental health sectors. This update lays the foundation for deeper collaboration and accountability across nations and sectors, emphasizing the One Health approach.
As part of the declaration, countries committed to concrete, measurable goals for reducing AMR by 2030. These include:
- A 10% reduction in global deaths associated with bacterial AMR compared to 2019 levels.
- Ensuring more appropriate antibiotic use through WHO’s AWaRe classification,
- Encourage all countries to report quality surveillance data on antimicrobial resistance.
At LIFE PharmaDetox, we are committed to raising awareness of and taking action against antimicrobial resistance. By aligning with international health strategies and supporting the best practices in surveillance, diagnosis and management, we are helping to create a healthier and safer world.